Lindbrook Capital’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $64.1K | Buy |
208
+111
| +114% | +$34.2K | 0.01% | 887 |
|
|
2024
Q4 | $34.2K | Buy |
97
+6
| +7% | +$2.12K | ﹤0.01% | 983 |
|
|
2024
Q3 | $32.6K | Buy |
91
+11
| +14% | +$3.94K | ﹤0.01% | 1019 |
|
|
2024
Q2 | $25.5K | Buy |
80
+26
| +48% | +$8.28K | ﹤0.01% | 1110 |
|
|
2024
Q1 | $12.4K | Sell |
54
-48
| -47% | -$11K | ﹤0.01% | 1455 |
|
|
2023
Q4 | $22.4K | Buy |
102
+61
| +149% | +$13.4K | ﹤0.01% | 1122 |
|
|
2023
Q3 | $9.26K | Buy |
41
+3
| +8% | +$678 | ﹤0.01% | 1456 |
|
|
2023
Q2 | $8.39K | Sell |
38
-21
| -36% | -$4.64K | ﹤0.01% | 1575 |
|
|
2023
Q1 | $13.2K | Buy |
59
+11
| +23% | +$2.46K | ﹤0.01% | 1280 |
|
|
2022
Q4 | $13.3K | Buy |
48
+19
| +66% | +$5.28K | ﹤0.01% | 1286 |
|
|
2022
Q3 | $6K | Buy |
29
+4
| +16% | +$828 | ﹤0.01% | 1607 |
|
|
2022
Q2 | $6K | Buy |
25
+10
| +67% | +$2.4K | ﹤0.01% | 1500 |
|
|
2022
Q1 | $3K | Buy |
15
+2
| +15% | +$400 | ﹤0.01% | 1888 |
|
|
2021
Q4 | $3K | Sell |
13
-6
| -32% | -$1.39K | ﹤0.01% | 1708 |
|
|
2021
Q3 | $4K | Buy |
19
+3
| +19% | +$632 | ﹤0.01% | 1354 |
|
|
2021
Q2 | $3K | Hold |
16
| – | – | ﹤0.01% | 1518 |
|
|
2021
Q1 | $3K | Buy |
16
+11
| +220% | +$2.06K | ﹤0.01% | 1470 |
|
|
2020
Q4 | $1K | Hold |
5
| – | – | ﹤0.01% | 1706 |
|
|
2020
Q3 | $1K | Buy |
+5
| New | +$1K | ﹤0.01% | 1667 |
|
|
2019
Q3 | – | Sell |
-40
| Closed | -$3K | – | 1540 |
|
|
2019
Q2 | $3K | Hold |
40
| – | – | ﹤0.01% | 1174 |
|
|
2019
Q1 | $4K | Hold |
40
| – | – | ﹤0.01% | 1134 |
|
|
2018
Q4 | $4K | Buy |
+40
| New | +$4K | ﹤0.01% | 1082 |
|